Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma

NCT02959879 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Resectable Pancreatic Duct Adenocarcinoma

Interventions

DRUG: FOLFOX neoadjuvant chemotherapy
DRUG: FOLFIRINOX neoadjuvant chemotherapy
PROCEDURE: curative surgery for resectable pancreatic duct adenocarcinoma
DRUG: Standard adjuvant chemotherapy
DRUG: adjuvant chemotherapy

Sponsor

University Hospital, Rouen

Collaborators

UNICANCER
Federation Francophone de Cancerologie Digestive
Federation of Research in Surgery (FRENCH)
GERCOR - Multidisciplinary Oncology Cooperative Group